{"article": [{"url": "https://www.marketwatch.com/story/jj-to-receive-1-billion-in-us-funding-to-make-100-million-doses-of-its-covid-19-vaccine-2020-08-05", "published": 1596617180.0, "headline": "J&J to receive $1 billion in U.S. funding to make 100 million doses of its COVID-19 vaccine", "body": "Shares of Johnson & Johnson JNJ, +1.39% gained 0.8% in premarket trading on Wednesday after the company said it will receive more than $1 billion from the U.S. government to manufacture 100 million doses of its investigational COVID-19 vaccine. The vaccine will be provided at a \"global not-for-profit basis for emergency pandemic use,\" J&J said. The company's vaccine candidate recently entered the Phase 1/2a clinical trial, which is taking place in Belgium and the U.S. J&J's stock is up 0.9% year-to-date, while the S&P 500 SPX, +0.87% has gained 2.3%."}]}